Jürgen Pohle provides both a fascinating and open account of the latest movements of Neovii; a company that possesses the ability to make decisions at the speed of a startup but also has a heritage dating back to the 1970s.
After an outstanding career spanning 25 years with Big Pharma players (Bayer, Novartis, GSK), you joined Neovii as Chief Commercial Officer in March 2016. Why at this stage of your career did you choose to join a pioneering biotech?
"We decided that we would like to create our own footprint in all of our key markets where the environment and the scale of our company permits us."
